Problem

Physical therapy practices need to keep patients engaged between visits and capture the clinical and administrative requirements of remote therapeutic monitoring (RTM), but doing so can add substantial operational work. Copper Health addresses this practice-level burden by helping providers improve patient outcomes while creating an opportunity for additional reimbursement; its core use case is making RTM practical for physical therapy practices without requiring them to build and manage the process themselves.

The economics are therefore two-sided: practices seek better adherence and outcomes for patients while also increasing reimbursable care. Copper Health’s positioning suggests that the main pain is not simply access to monitoring technology, but the workflow required to deliver RTM reliably and turn it into a sustainable part of a practice’s care model.

Product / Service

Copper Health presents itself as a full-service remote therapeutic monitoring partner and an AI-powered patient engagement and RTM platform for physical therapy practices. The model combines technology with operational support: the platform supports patient engagement and holistic care, while Copper Health handles the entire RTM process so the practice does not have to take on additional work.

The benefit is a more effortless RTM workflow for providers, with the potential to extend care beyond the clinic, improve patient outcomes, and increase reimbursements. The available evidence does not provide a detailed description of the software interface, pricing, or exact clinician and patient workflow, so the clearest characterization is a managed RTM service built around a patient-engagement platform.

Market

Copper Health competes in digital health and healthcare enterprise systems, specifically the remote therapeutic monitoring and patient-engagement category serving physical therapy practices. Its public materials identify the target customer and use case clearly, but the available company and directory descriptions do not name specific competitors; therefore, no competitor list can be established from the research.

The company appears to be an early-stage venture rather than a scaled operator. It was founded in 2024, participated in Y Combinator’s Winter 2024 cohort, is listed as active, and has been reported as having raised $500,000 in pre-seed funding. Public revenue, customer-count, and outcome metrics were not identified, so its revenue status and commercial traction beyond funding and accelerator participation cannot be confirmed.